The management of heroin misuse in pregnancy: Time for a rethink?

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 96, Issue 6, 2011, Pages

  Mactier, Helen ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

BUPRENORPHINE; CLONIDINE; DIAMORPHINE; METHADONE; MORPHINE; NALTREXONE;

BRAIN DEVELOPMENT; BRAIN GROWTH; COGNITIVE DEFECT; DRUG EFFECT; DRUG MISUSE; EVOKED VISUAL RESPONSE; FETUS OUTCOME; HEROIN DEPENDENCE; HUMAN; INFECTION RISK; LIFESTYLE; MYELINATION; NERVE CELL DIFFERENTIATION; NEWBORN MORBIDITY; NEWBORN MORTALITY; NONHUMAN; NYSTAGMUS; POSTNATAL GROWTH; PREGNANCY; PRIORITY JOURNAL; REFRACTION ERROR; REVIEW; STRABISMUS; UNITED KINGDOM; VISUAL IMPAIRMENT; VISUAL SYSTEM; WITHDRAWAL SYNDROME;

BUPRENORPHINE; CHILD, PRESCHOOL; DEVELOPMENTAL DISABILITIES; FEMALE; HEROIN DEPENDENCE; HUMANS; INFANT; INFANT, NEWBORN; MATERNAL-FETAL EXCHANGE; METHADONE; OPIATE SUBSTITUTION TREATMENT; PREGNANCY; PREGNANCY COMPLICATIONS; PRENATAL CARE; PRENATAL EXPOSURE DELAYED EFFECTS;

EID: 80054727928     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/adc.2009.181057     Document Type: Review

References (42)

1. Heroin timeline. Heroin addiction drug rehab, 2010. Available at http://www.heroinaddiction.com/heroin-timeline.html (Accessed 15 March 2010).
2. Griffiths P, Gossop M, Powis B, et al. Transitions in patterns of heroin administration: a study of heroin chasers and heroin injectors. Addiction 1994;89:301-9. (Pubitemid 24062068)
3. NHS Information Centre for Health and Social Care. Statistics and data collection. Available at http://www.ic.nhs.uk (Accessed 12 June 2010).
4. NHS Services Scotland. Drug Misuse Statistics Scotland 2008 (published 16 Feb 2009). Available at http://www.audit-scotland.gov.uk/docs/.../nr-090326- drugs-alcohol.pdf (Accessed 15 March 2010).
5. Dryden C, Young D, Hepburn M, et al. Maternal methadone use in pregnancy: factors associated with the development of neonatal abstinence syndrome and implications for healthcare resources. BJOG 2009;116:665-71.
6. Fajemirokun-Odudeyi O, Sinha C, Tutty S, et al. Pregnancy outcome in women who use opiates. Eur J Obstet Gynecol Reprod Biol 2006;126:170-5.
7. Hulse GK, Milne E, English DR, et al. Assessing the relationship between maternal opiate use and antepartum haemorrhage. Addiction 1998;93:1553-8. (Pubitemid 28472995)
8. Alroomi LG, Davidson J, Evans TJ, et al. Maternal narcotic abuse and the newborn. Arch Dis Child 1988;63:81-3. (Pubitemid 18054209)
9. Minozzi S, Amato L, Vecchi S, et al. Maintenance agonist treatments for opiate dependent pregnant women. Cochrane Database Syst Rev 2008;2:CD006318.
10. Annitto WJ. Detoxification with buprenorphine of a pregnant heroin addict. Am J Addict 2000;9:92-3. (Pubitemid 30155038)
11. Winklbaur B, Kopf N, Ebner N, et al. Treating pregnant women dependent on opioids is not the same as treating pregnancy and opioid dependence: a knowledge synthesis for better treatment for women and neonates. Addiction 2008;103:1429-40.
12. Loustauneau A, Auriacombe M, Daulouede JP, et al. [Is buprenorphine a potential alternative to methadone for treating pregnant drug users? Inventory of clinical data in the literature]. Ann Med Interne (Paris) 2002;153:2S31-6.
13. Fischer G, Jagsch R, Eder H, et al. Oral slow release morphine in pregnant opioid addicts. Addiction 1999;94:231-9.
14. Hartwig C, Haasen C, Reimer J, et al. Pregnancy and birth under maintenance treatment with diamorphine (heroin): a case report. Eur Addict Res 2008;14:113-14. (Pubitemid 351365644)
15. Farid WO, Dunlop SA, Tait RJ, et al. The effects of maternally administered methadone, buprenorphine and naltrexone on offspring: review of human and animal data. Curr Neuropharmacol 2008;6:125-50. (Pubitemid 352024797)
16. Dole VP, Nyswander M. A medical treatment for diacetylmorphine (heroin) addiction. a clinical trial with methadone hydrochloride. JAMA 1965;193:646-50.
17. UK Guidelines 2007. Department of Health (England), The Scottish Government, Welsh Assembly Government, Northern Ireland Executive, Drug Misuse and Dependence: UK Guideline on Clinical Management, 2007. http://www.smmgp.org. uk (Accessed 14 June 2010).
18. Marsch LA. The efficacy of methadone maintenance interventions in reducing illicit opiate use, HIV risk behavior and criminality: a meta-analysis. Addiction 1998;93:515-32. (Pubitemid 28188071)
19. Hulse GK, Milne E, English DR, et al. The relationship between maternal use of heroin and methadone and infant birth weight. Addiction 1997;92:1571-9. (Pubitemid 27499568)
20. McGlone L, Mactier H, Hamilton R, et al. Visual evoked potentials in infants exposed to methadone in utero. Arch Dis Child 2008;93:784-6.
21. van Baar AL, Fleury P, Soepatmi S, et al. Neonatal behavior after drug dependent pregnancy. Arch Dis Child 1989;64:235-40. (Pubitemid 19053755)
22. Eap CB, Buclin T, Baumann P. Interindividual variability of the clinical pharmacokinetics of methadone: implications for the treatment of opioid dependence. Clin Pharmacokinet 2002;41:1153-93. (Pubitemid 35398691)
23. Fischer G, Ortner R, Rohrmeister K, et al. Methadone versus buprenorphine in pregnant addicts: a double-blind, double-dummy comparison study. Addiction 2006;101:275-81. (Pubitemid 43351601)
24. Jones HE, Johnson RE, Jasinski DR, et al. Buprenorphine versus methadone in the treatment of pregnant opioid-dependent patients: effects on the neonatal abstinence syndrome. Drug Alcohol Depend 2005;79:1-10. (Pubitemid 41557119)
25. Whitham JN, Spurrier NJ, Sawyer MG, et al. The effects of prenatal exposure to buprenorphine or methadone on infant visual evoked potentials. Neurotoxicol Teratol 2010;32:280-8.
26. Vatury O, Barg J, Slotkin TA, et al. Altered localization of choline transporter sites in the mouse hippocampus after prenatal heroin exposure. Brain Res Bull 2004;63:25-32. (Pubitemid 38581937)
27. Darmani NA, Schnoll SH, Pandey U, et al. Chronic prenatal methadone exposure alters central opioid mu-receptor affinity in both fetal and maternal brain. Neurotoxicol Teratol 1992;14:265-71.
28. Robinson SE, Maher JR, Wallace MJ, et al. Perinatal methadone exposure affects dopamine, norepinephrine, and serotonin in the weanling rat. Neurotoxicol Teratol 1997;19:295-303. (Pubitemid 27326884)
29. Sanchez ES, Bigbee JW, Fobbs W, et al. Opioid addiction and pregnancy: perinatal exposure to buprenorphine affects myelination in the developing brain. Glia 2008;56:1017-27.
30. Hunt RW, Tzioumi D, Collins E, et al. Adverse neurodevelopmental outcome of infants exposed to opiate in-utero. Early Hum Dev 2008;84:29-35.
31. Rosen TS, Johnson HL. Children of methadone-maintained mothers: follow-up to 18 months of age. J Pediatr 1982;101:192-6. (Pubitemid 12098765)
32. Ornoy A, Michailevskaya V, Lukashov I, et al. The developmental outcome of children born to heroin-dependent mothers, raised at home or adopted. Child Abuse Negl 1996;20:385-96. (Pubitemid 26138636)
33. Ornoy A, Segal J, Bar-Hamburger R, et al. Developmental outcome of school-age children born to mothers with heroin dependency: importance of environmental factors. Dev Med Child Neurol 2001;43:668-75. (Pubitemid 32982227)
34. Lifschitz MH, Wilson GS, Smith EO, et al. Factors affecting head growth and intellectual function in children of drug addicts. Pediatrics 1985;75:269-74. (Pubitemid 15164788)
35. Wilson GS, McCreary R, Kean J, et al. The development of preschool children of heroin-addicted mothers: a controlled study. Pediatrics 1979;63:135-41. (Pubitemid 9111213)
36. Chavez C, Ostrea EM, Stryker JC, et al. Ocular abnormalities in infants as sequelae of prenatal drug addiction. Pediatr Res 1979;13:367.
37. McGlone L, Mactier H, Weaver LT. Drug misuse in pregnancy: losing sight of the baby? Arch Dis Child 2009;94:708-12.
38. Hamilton R, McGlone L, Mackinnon JR, et al. Ophthalmic, clinical and visual electrophysiological findings in children born to mothers prescribed substitute methadone in pregnancy. Br J Ophthalmol 2010;94:696-700.
39. Gill AC, Oei J, Lewis NL, et al. Strabismus in infants of opiate-dependent mothers. Acta Paediatr 2003;92:379-85. (Pubitemid 36408094)
40. Mulvihill AO, Cackett PD, George ND, et al. Nystagmus secondary to drug exposure in utero. Br J Ophthalmol 2007;91:613-15. (Pubitemid 46716528)
41. Pinto F, Onofrj M, Pola P, et al. Fetal addiction to methadone: postnatal abstinence syndrome and development of visual evoked potentials. Drug Alcohol Depend 1986;18:1-10. (Pubitemid 16027697)
42. Bauer LO. Effects of chronic opioid dependence and HIV-1 infection on pattern shift visual evoked potentials. Drug Alcohol Depend 1998;50:147-55. (Pubitemid 28271629)